Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription 22.08.2022 6 Am J Cardiol 2 Am J Med 7 Angiology 6 Can J Cardiol 1 Catheter Cardiovasc Interv 2 Circ Cardiovasc Interv 1 Circ Genom Precis Med 1 Circ J 4 Circulation 2 Heart 1 Hypertension 2 Int J Cardiol 2 J Cardiovasc Pharmacol 2 J Clin Endocrinol Metab 3 J Thorac Cardiovasc Surg 2 JAMA 4 PLoS One 1 Psychosom Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. GABARIN M, Hornik-Lurie T, Minha S, Omelchenko A, et al
   CHA2DS2-VASc Score, Mortality and Acute Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation.
   Am J Cardiol. 2022 Aug 12. pii: S0002-9149(22)00702.
   PubMed         Abstract available
   
   
2. GORGIS S, Ehrman JK, Blaha MJ, Qureshi WT, et al
   Relation of Exercise Capacity to Incident Heart Failure Among Men and Women With Coronary Heart Disease (from the Henry Ford Exercise Testing [FIT] Project).
   Am J Cardiol. 2022 Aug 12. pii: S0002-9149(22)00746.
   PubMed         Abstract available
   
   
3. PATOULIAS D, Papadopoulos C, Fragakis N, Doumas M, et al
   Updated Meta-Analysis Assessing the Cardiovascular Efficacy of Tirzepatide.
   Am J Cardiol. 2022 Aug 14. pii: S0002-9149(22)00734.
   PubMed        
   
   
4. OBAYASHI Y, Shiomi H, Morimoto T, Tamaki Y, et al
   Stroke Risk Stratification With the CHADS2 Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention.
   Am J Cardiol. 2022 Aug 13. pii: S0002-9149(22)00736.
   PubMed         Abstract available
   
   
5. DYKUN I, Clark D 3rd, Carlo J, Lincoff AM, et al
   Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease.
   Am J Cardiol. 2022 Aug 12. pii: S0002-9149(22)00735.
   PubMed         Abstract available
   
   
6. DOOLUB G, Kobo O, Mohamed MO, Ullah W, et al
   Corrigendum to 'Outcomes of Percutaneous Coronary Intervention in Patients With Acquired Immunosuppression' The American Journal of Cardiology Volume 171, 15 May 2022, Pages 40-48.
   Am J Cardiol. 2022;178:180.
   PubMed        
   
   

   
   Am J Med

7. ALPERT J
   New coronary heart disease risk factors.
   Am J Med. 2022 Aug 15. pii: S0002-9343(22)00569.
   PubMed        
   
   
8. SEREBRUANY VL, Tanguay JF, Kuliczkowski W, Heidel E, et al
   Impact of Bleeding on Myocardial Infarction, Stroke and Death During 12-months Dual Antiplatelet Therapy After Acute Coronary Syndrome.
   Am J Med. 2022 Aug 15. pii: S0002-9343(22)00573.
   PubMed         Abstract available
   
   

   
   Angiology

9. WANG K, Ding Y, Wang R, Yang J, et al
   Remnant Cholesterol and the Risk of Coronary Artery Disease in Patients With Type 2 Diabetes.
   Angiology. 2022 Aug 14:33197221121008. doi: 10.1177/00033197221121008.
   PubMed         Abstract available
   
   
10. YUKSEL Y, Kose S
    Prognostic Nutritional Index Predicts Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome.
    Angiology. 2022 Aug 14:33197221116203. doi: 10.1177/00033197221116203.
    PubMed         Abstract available
    
    
11. MANOLIS AS, Manolis TA
    Thrombus Aspiration in Acute Myocardial Infarction: A Long-Awaited Resurgence?
    Angiology. 2022 Aug 13:33197221121003. doi: 10.1177/00033197221121003.
    PubMed        
    
    
12. AYDIN E, Aydin S, Gul M, Yetim M, et al
    Influence of Intermittent Fasting During Ramadan on Circadian Variation of Symptom-Onset and Prehospital Time Delay in Acute ST-Segment Elevation Myocardial Infarction.
    Angiology. 2022 Aug 17:33197221114087. doi: 10.1177/00033197221114087.
    PubMed         Abstract available
    
    
13. HATEM E, Aslan O, Demirci EE, Yildirim S, et al
    Relationship Between Prognostic Nutritional Index and Contrast-Associated Acute Kidney Injury in Patients With Non-ST Segment Elevation Myocardial Infarction Undergoing Coronary Angiography.
    Angiology. 2022 Aug 17:33197221113158. doi: 10.1177/00033197221113158.
    PubMed         Abstract available
    
    
14. AKSAKAL E, Aksu U, Birdal O, Ozturk M, et al
    Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients With ST-Elevated Myocardial Infarction.
    Angiology. 2022 Aug 17:33197221121435. doi: 10.1177/00033197221121435.
    PubMed         Abstract available
    
    
15. BHASIN V, Hiltner E, Singh A, Elsaid O, et al
    Disparities in Drug-Eluting Stent Utilization in Patients With Acute ST-Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample.
    Angiology. 2022 Aug 17:33197221121027. doi: 10.1177/00033197221121027.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

16. CHEW NWS, Zhang A, Ong J, Koh S, et al
    Long-term Prognosis in Patients With Concomitant Acute Coronary Syndrome and Aortic Stenosis.
    Can J Cardiol. 2022;38:1220-1227.
    PubMed         Abstract available
    
    
17. TEHRANI BN, Drakos SG, Billia F, Batchelor WB, et al
    The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design.
    Can J Cardiol. 2022;38:1286-1295.
    PubMed         Abstract available
    
    
18. RAO K, Granger E, Dvir D, Fahmy P, et al
    BASILICA Technique for Prevention of Coronary Artery Occlusion in High-Risk Native Transcatheter Aortic Valve Replacement.
    Can J Cardiol. 2022;38:1312-1314.
    PubMed        
    
    
19. TERADA T, Cotie LM, Tulloch H, Mistura M, et al
    Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    Can J Cardiol. 2022;38:1235-1243.
    PubMed         Abstract available
    
    
20. THOMPSON CR
    Acute Coronary Syndrome and Aortic Stenosis: A Lethal Combo!
    Can J Cardiol. 2022;38:1130-1131.
    PubMed        
    
    
21. PARLOW S, Weng W, Di Santo P, Jung RG, et al
    Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
    Can J Cardiol. 2022;38:1211-1219.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

22. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

23. BJARNASON TA, Mentias A, Panaich S, Vaughan Sarrazin M, et al
    Diffusion of Percutaneous Ventricular Assist Devices in US Markets.
    Circ Cardiovasc Interv. 2022;15:e011778.
    PubMed         Abstract available
    
    
24. CHAITMAN BR, Cyr DD, Alexander KP, Pracon R, et al
    Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
    Circ Cardiovasc Interv. 2022;15:e012103.
    PubMed         Abstract available
    
    

    
    Circ Genom Precis Med

25. WELDY CS, Murtha R, Kim JB
    Dissecting the Genomics of Spontaneous Coronary Artery Dissection.
    Circ Genom Precis Med. 2022 Aug 18:101161CIRCGEN122003867.
    PubMed        
    
    

    
    Circ J

26. OKAMOTO H, Nishi T, Ishii M, Tsujita K, et al
    Clinical Characteristics and Outcomes of Patients Presenting With Acute Myocardial Infarction Without Cardiogenic Shock.
    Circ J. 2022 Aug 11. doi: 10.1253/circj.CJ-22-0241.
    PubMed         Abstract available
    
    

    
    Circulation

27. SARNAK MJ, Auguste BL, Brown E, Chang AR, et al
    Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Aug 15:101161CIR0000000000001088.
    PubMed         Abstract available
    
    
28. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
    State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Aug 18:101161CIR0000000000001089.
    PubMed         Abstract available
    
    
29. SANDOVAL Y, Apple FS, Mahler SA, Body R, et al
    High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.
    Circulation. 2022;146:569-581.
    PubMed         Abstract available
    
    
30. UDELSON JE, Selker HP, Braunwald E
    Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook.
    Circulation. 2022;146:503-505.
    PubMed        
    
    

    
    Heart

31. SIEGERSMA KR, Onland-Moret NC, Appelman Y, van der Harst P, et al
    Outcomes in patients with a first episode of chest pain undergoing early coronary CT imaging.
    Heart. 2021 Nov 15. pii: heartjnl-2021-319747. doi: 10.1136/heartjnl-2021-319747
    PubMed         Abstract available
    
    
32. SILVERIO A, Parodi G, Scudiero F, Bossone E, et al
    Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome.
    Heart. 2022;108:1369-1376.
    PubMed         Abstract available
    
    

    
    Hypertension

33. TRIMARCO V, Izzo R, Morisco C, Mone P, et al
    High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients.
    Hypertension. 2022 Aug 15:101161HYPERTENSIONAHA12219912.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

34. CHEN Y, Wu J, Tang Y, Li Z, et al
    Multimorbidity and combined interventions for patients with coronary heart disease in Chinese population: Latent class analysis of a multi-center study.
    Int J Cardiol. 2022 Aug 10. pii: S0167-5273(22)01189.
    PubMed         Abstract available
    
    
35. LI Q, Xie E, Tu Y, Wu Y, et al
    Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2022 Aug 12. pii: S0167-5273(22)01193.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

36. ANTO S, Sathish V, Sun C, O'Rourke ST, et al
    Apelin-Induced Relaxation of Coronary Arteries is Impaired in a Model of Second-Hand Cigarette Smoke Exposure.
    J Cardiovasc Pharmacol. 2022 Aug 11. pii: 00005344-990000000-00093.
    PubMed         Abstract available
    
    
37. HUI J, Bai T, Liang L, He Q, et al
    Efficacy and Safety of Shortened Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2022 Aug 15. pii: 00005344-990000000-00094.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

38. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
    J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666536. doi: 10.1210.
    PubMed         Abstract available
    
    
39. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089).
    J Clin Endocrinol Metab. 2022 Aug 16. pii: 6666536. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

40. HAYWOOD N, Kron IL
    Commentary: The over and under on ischemic mitral regurgitation repair.
    J Thorac Cardiovasc Surg. 2020 Oct 20. pii: S0022-5223(20)32836.
    PubMed        
    
    
41. CASTILLO-SANG M, Nguyen TC, Voeller RK
    Commentary: Ischemic mitral regurgitation: From annular restriction to papillary approximation, is it time to reconsider the lost technique?
    J Thorac Cardiovasc Surg. 2020 Oct 22. pii: S0022-5223(20)32876.
    PubMed        
    
    
42. WANG AS, Nemeth S, Kurlansky P, Brodie D, et al
    Sex differences in patients with cardiogenic shock requiring extracorporeal membrane oxygenation.
    J Thorac Cardiovasc Surg. 2022;164:960-969.
    PubMed         Abstract available
    
    

    
    JAMA

43. SARKAR U, Bibbins-Domingo K
    Achieving Diagnostic Equity in Cardiovascular Disease.
    JAMA. 2022 Aug 15. pii: 2795499. doi: 10.1001/jama.2022.14424.
    PubMed        
    
    
44. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    PubMed         Abstract available
    
    

    
    PLoS One

45. TSAI CT, Lu YW, Chou RH, Kuo CS, et al
    Effect of timing of coronary revascularization in patients with post-infectious myocardial infarction.
    PLoS One. 2022;17:e0272258.
    PubMed         Abstract available
    
    
46. MURASATO Y, Meno K, Mori T, Tanenaka K, et al
    Impact of coronary bifurcation angle on the pathogenesis of atherosclerosis and clinical outcome of coronary bifurcation intervention-A scoping review.
    PLoS One. 2022;17:e0273157.
    PubMed         Abstract available
    
    
47. BJOERNSBO KS, Joensen AM, Joergensen T, Lundbye-Christensen S, et al
    Quantifying benefits of the Danish transfat ban for coronary heart disease mortality 1991-2007: Socioeconomic analysis using the IMPACTsec model.
    PLoS One. 2022;17:e0272744.
    PubMed         Abstract available
    
    
48. GONZALEZ-PACHECO H, Gopar-Nieto R, Araiza-Garaygordobil D, Briseno-Cruz JL, et al
    Application of the SCAI classification to admission of patients with cardiogenic shock: Analysis of a tertiary care center in a middle-income country.
    PLoS One. 2022;17:e0273086.
    PubMed         Abstract available
    
    

    
    Psychosom Med

49. SUGLIA SF, Hardy ST, Cammack AL, Kim YJ, et al
    Child Maltreatment and Inflammatory Response to Mental Stress Among Adults who Have Survived a Myocardial Infarction.
    Psychosom Med. 2022 Aug 2. pii: 00006842-990000000-00046.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: